Answers are grounded in this paper and cite their sources.
The fragmentation of pharmaceutical regulatory systems across Africa's 55 nations constitutes one of the most consequential structural barriers to universal health coverage on the continent, generating an estimated USD 2.5 to 3.8 billion in annual avoidable costs through duplicative regulatory assessment processes, delayed medicine registration, proliferation of substandard and falsified medicines, and procurement inefficiency attributable to limited competition in fragmented national markets. Each African country operates an independent national medicines regulatory authority whose technical capacity, dossier format requirements, quality standards, and postmarket surveillance architecture diverge substantially from those of neighboring jurisdictions, collectively requiring pharmaceutical manufacturers seeking pan-African market access to complete 55 separate registration processes with a combined completion timeline of 15 to 25 years and total compliance costs exceeding USD 100 million per product. This regulatory fragmentation directly undermines access to quality-assured essential medicines for Africa's 1.4 billion population and systematically disadvantages African patients relative to counterparts in regulatory harmonization zones where centralized or mutually recognized registration enables continental market access within 12 to 18 months. This paper presents the African Regulatory Convergence and Harmonization Model (ARCH-Model), a four-phase continental regulatory integration framework designed to achieve continental-scale harmonization of pharmaceutical regulatory systems across Africa's Regional Economic Communities within a 15 to 25-year implementation horizon. The four phases are: Phase 1 National Foundation Building, Phase 2 REC-Level Technical Harmonization, Phase 3 Mutual Recognition Architecture, and Phase 4 AMA Continental Governance. The model integrates evidence from WHO regulatory system strengthening initiatives, the African Medicines Regulatory Harmonization programme, the African Medicines Agency treaty, ASEAN and EU harmonization precedents, industrial safety governance and environmental risk management frameworks, supply chain governance, digital platform architecture, healthcare infrastructure capacity assessment, data governance design, and agricultural development policy alignment. The paper specifies phase deliverables, governance standards, REC capacity profiles, digital infrastructure architecture (PARIS), multi-source financing mechanisms, stakeholder engagement frameworks, and an economic analysis demonstrating net present value of USD 24 to 60 billion over 25 years against total investment of USD 1.5 to 2.8 billion.
No takes yet. Share an insight, caveat, or question.
Felix Ikechukwu Eze (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: